Vnitr Lek 2007, 53(4):354-358

Chronic pancreatitis - etiological classifications and diagnostic criteria

P. Dítě
Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Petr Dítě, DrSc.

Current etiological classifications divide chronic pancreatitis into a toxo-nutritive form where the main agent is alcohol, and an idiopathic genetically induced form, an auto-immune form, and a recidivistic and obstructive form. It is clear that the different etiologies of the illness are associated with different histological findings. Knowledge of these is vitally important for targeted therapy and assessment of the progress of the disease. Even though chronic pancreatitis is still defined as a chronic, longstanding progressive process of fibrosis of the gland, it has been shown that precisely due to histological differences in the morphology of the gland, the chronic autoimmune form behaves completely differently during corticoid therapy than the alcohol-induced form or the obstructive form. It seems that in the near future it will be necessary to change the definition of the illness as we know it today and change the existing algorithms for diagnosis and subsequent therapy.

Keywords: chronic pancreatitis; idiopathic form; autoimmune form

Received: February 16, 2007; Published: April 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dítě P. Chronic pancreatitis - etiological classifications and diagnostic criteria. Vnitr Lek. 2007;53(4):354-358.
Download citation

References

  1. Dítě P, Starý K, Novotný I et al. Incidence of chronic pancreatitis in Czech republic. Europ J Gastroent Hepatol 2001; 13: 749-750. Go to original source... Go to PubMed...
  2. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707. Go to original source... Go to PubMed...
  3. Sarles H, Adler G, Dani R et al. The pancreatitis classification of Marseilles-Rome 1998. Scand J Gastroenterol 1989; 24: 641-642. Go to original source...
  4. Sarner M, Cotton PB. Classification of pancreatitis. Gut 1984; 25: 756-759. Go to original source... Go to PubMed...
  5. Singer MV, Gyr K, Sarles H. Revised classification of pancreatitis: Report of the Second international symposium on the classification of pancreatitis in Marseille, France, March 28-30 1984. Gastroenterology 1985; 89: 683-685. Go to original source...
  6. Sarner M, Cotton PB. Definitions of acute and chronic pancreatitis. Clin Gastroenterol 1984; 13: 865-870. Go to original source... Go to PubMed...
  7. Apte MV, Haber PS, Norton ID et al. Alcohol and the pancreas. Addict Biol 1998; 3: 137-150. Go to original source... Go to PubMed...
  8. Layer P, Yamamoto H, Kalthoff L et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481-1487. Go to original source... Go to PubMed...
  9. Lankisch PG. Natural course of chronic pancreatitis. Pancreatology 2001; 1: 3-14. Go to original source... Go to PubMed...
  10. Yoshida K, Toki F, Takuchi T et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40: 1561-1568. Go to original source... Go to PubMed...
  11. Sarles H, Sarles JC, Camatte R et al. Chronic inflammatory sclerosing of the pancreas - An autonomous pancreatic disease? Am J Dig Dis 1961; 6: 688-698. Go to original source... Go to PubMed...
  12. Sahani DV. Autoimmune pancreatitis: imaging features. Radiology 2004; 233: 345-352. Go to original source... Go to PubMed...
  13. Kim KP. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99: 1605-1616. Go to original source... Go to PubMed...
  14. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51: 1-4. Go to original source... Go to PubMed...
  15. Kamisawa T, Egawa N, Inokuma S et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004; 39: 1154-1158. Go to original source... Go to PubMed...
  16. Horiuchi A, Kawa S, Akamatsu T et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: A case report and review of the Japanese literature. Am J Gastroenterol 1998; 93: 200-263. Go to original source... Go to PubMed...
  17. Ito T, Nakano I, Koyanagi S et al. Autoimmune pancreatitis as a new clinical entity: Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 1997; 42: 1458-1468. Go to original source... Go to PubMed...
  18. Kahl S, Glasbrenner B, Leodolter A et al. EUS in the diagnosis of early chronic pancreatitis: A prospective follow-up study. Gastrointest Endosc 2002; 55: 507-511. Go to original source... Go to PubMed...
  19. Wallace MB, Hawes RH. Endoscopic ultrasound in the evaluation and treatment of chronic pancreatitis. Pancreas 2001; 23: 26-35. Go to original source... Go to PubMed...
  20. Dítě P, Ševčíková A, Novotný I et al. Autoimune pancreatitis in Czech republic. - Czech and Slovak Gastroenterol and Hepatol 2007 (v tisku).
  21. Otsuki M. Chronic pancreatitis. Pancreaology 2004; 4: 28-41. Go to original source... Go to PubMed...
  22. Yagura M, Murai S, Kojima H et al. Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon - alpha therapy: Including quantitative assessment by a morphometric method. J Gastroenterol 2000; 35: 105-111. Go to original source... Go to PubMed...
  23. Shiratori Y, Imazeki F, Moriyama M et al. Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132: 517-524. Go to original source... Go to PubMed...
  24. Kloppel G, Luttges J, Löhr M et al. Autoimmune pancreatitis: pathological, clinical and immunological features. Pancreas 2003; 27: 14-19. Go to original source... Go to PubMed...
  25. Furukawa N, Muranaka T, Yasumori K et al. Autoimmune pancreatitis: Radiologic findings in three histologically proven cases. J Comput Assist Tomogr 1998; 22: 880-883. Go to original source... Go to PubMed...
  26. Pitchumoni CS, Glasser M, Saran RM et al. Pancreatic fibrosis in chronic alcoholics and nonalcoholics without clinical pancreatitis. Am J Gastroenterol 1984; 79: 382-388.
  27. Sica GT, Miller FH, Rodriguez G et al. Magnetic resonance imaging in patients with pancreatitis: Evaluation of signal intensity and enhancement changes. J Magn Reson Imaging 2002; 15: 275-284. Go to original source... Go to PubMed...
  28. Novotný I. Endoskopická sonografie v diagnostice časné chronické pankreatitidy. Vnitř Lék 2000; 46: 704-708. Go to PubMed...
  29. Lowenfels AB, Maisonneuve P, Cavallini G et al. Pancreatitis and the risk of pancreatic cancer: Intenational Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437. Go to original source... Go to PubMed...
  30. Ekbom A, McLaughlin JK, Karlsson BM et al. Pancreatitis and pancreatic cancer: A population-based study. J Natl Cancer Inst 1994; 86: 625-627. Go to original source... Go to PubMed...
  31. Talamini G, Falconi M, Bassi C et al. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 1999; 94: 1253-1260. Go to original source... Go to PubMed...
  32. Chari ST, Mohan V, Pitchumoni CS et al. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: An epidemiologic study. Pancreas 1994; 9: 62-66. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.